查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
幹細胞治療的全球市場:各細胞來源(脂肪組織來源MSC，骨髓來源MSC，胎盤/臍帶來源MSC，其他)，各類型，各治療用途，各地區的市場規模調查與預測(2022年～2028年)
市場調查報告書
商品編碼
1070328

幹細胞治療的全球市場:各細胞來源(脂肪組織來源MSC，骨髓來源MSC，胎盤/臍帶來源MSC，其他)，各類型，各治療用途，各地區的市場規模調查與預測(2022年～2028年)

Global Stem Cell Therapy Market Size study, By Cell Source (Adipose tissue-derived MSCs, Bone marrow-derived MSCs, Placental/umbilical cord-derived MSCs, Other Cell Sources), By Type, By Therapeutic Application, and Regional Forecasts 2022-2028
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

全球幹細胞治療的市場規模，2021年從約1億6,052萬美金，2022年到2028年的預測期間內預計以16.5％以上的健全成長率擴大。

本報告提供全球幹細胞治療市場調查，市場概要，市場分析，各細胞來源、各類型、各治療用途、各地區的分析，及競爭情形等全面性資訊。

目錄

第1章 摘要整理

第2章 全球幹細胞治療市場定義和範圍

第3章 全球幹細胞治療市場動態

  • 幹細胞治療市場影響分析(2020年～2028年)

第4章 全球幹細胞治療市場產業分析

  • 波特的五力分析
  • PEST分析
  • 投資採用模式
  • 分析師的推薦事項與結論
  • 主要的投資機會
  • 主要的成功策略

第5章 風險評估:COVID-19影響

    • COVID-19對產業的整體影響的評估
    • COVID-19前及COVID-19後的市場情境

第6章 全球幹細胞治療市場:各細胞來源

  • 市場概述
  • 成果 - 潛力分析:各細胞來源
  • 市場規模的估計與預測:各細胞來源，2019年～2028年(100萬美元)
  • 子區隔分析
    • 脂肪組織來源MSC(間質幹細胞)
    • 骨髓來源MSC
    • 胎盤/臍帶來源MSC
    • 其他

第7章 全球幹細胞治療市場:各類型

  • 市場概述
  • 成果 - 潛力分析:各類型
  • 市場規模的估計與預測:各類型，2019年～2028年(100萬美元)
  • 子區隔分析
    • 同類幹細胞治療
    • 自體幹細胞治療

第8章 全球幹細胞治療市場:各治療用途

  • 市場概述
  • 成果 - 潛力分析:各治療用途
  • 市場規模的估計與預測:各治療用途，2019年～2028年(100萬美元)
  • 子區隔分析
    • 肌肉骨骼系統疾病
    • 創傷、外傷
    • 心血管疾病
    • 手術
    • 發炎性疾病、自體免疫疾病
    • 神經系統疾病
    • 其他

第9章 全球幹細胞治療市場，地區分析

  • 地區市場概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 其他
  • 南美
    • 巴西
    • 墨西哥
  • 其他地區

第10章 競爭資訊

  • 主要的市場策略
  • 企業簡介
    • MEDIPOST
    • Anterogen
    • Regrow Biosciences
    • Stempeutics Research
    • CORESTEM
    • PHARMICELL
    • NuVasive
    • RTI Surgical
    • AlloSource
    • JCR Pharmaceuticals

第11章 調查流程

Global Stem Cell Therapy Market is valued approximately USD 160.52 million in 2021 and is anticipated to grow with a healthy growth rate of more than 16.5% over the forecast period 2022-2028.

Stem cells are cells with the ability to grow into various different forms of cells in both animal and human bodies. These cells are majorly served as a repair system for the body and are often used in medicine and surgery. Stem cell therapy is also commonly called centerpiece therapy or regenerative medicine. Regenerative medications have the potential to revive cells and replace those that have been damaged or died. This cell therapy is used to treat a variety of chronic conditions, involves blood and cancer disorders. The growing prevalence of chronic disorders, availability of funding for stem cell research, increasing number of approvals for cell therapy production facilities, coupled with the rising clinical trials for stem cell based-therapies are the primary factors that may surge the market demand across the globe. For instance, in September 2020, Stemedica Cell Technologies get investigational new drug (IND) approval by the US FDA for the its intravenous allogeneic mesenchymal stem cells (MSCs) for curing moderate to severe COVID-19 patients. Moreover, increasing initiatives by the public and private organizations to spread awareness and development in medical technology, along with rising government investments in healthcare facilities are further factors, which, in turn, surge the global market demand. However, the high cost of cell-based research and ethical concerns associated with the embryonic stem cells impede the growth of the market over the forecast period of 2022-2028. Also, growing demand for cell & gene therapies and the emergence of induced pluripotent stem cells (iPSCs) as an alternative to Embryonic stem cells (ESCs) are anticipated to act as a catalyzing factor for the market demand during the forecast period.

The key regions considered for the global Stem Cell Therapy Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the increasing number of clinical trials and growing public-private funding and research grants for evolving safe & effective stem cell therapy products. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as increasing government support, growing investment in the healthcare sector, as well an escalating patient pool, would create lucrative growth prospects for the Stem Cell Therapy Market across the Asia-Pacific region.

Major market players included in this report are:

MEDIPOST

Anterogen

Regrow Biosciences

Stempeutics Research

CORESTEM

PHARMICELL

NuVasive

RTI Surgical

AlloSource

JCR Pharmaceuticals

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Cell Source

Adipose Tissue-Derived Mscs (Mesenchymal Stem Cells),

Bone Marrow-Derived Mscs,

Placental/Umbilical Cord-Derived Mscs, And

Other Cell Sources

By Type

Allogeneic Stem Cell Therapy

Autologous Stem Cell Therapy

By Therapeutic Application

Musculoskeletal Disorders

Wounds & Injuries,

Cardiovascular Diseases

Surgeries,

Inflammatory & Autoimmune Diseases

Neurological Disorders,

Other

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Stem Cell Therapy Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
    • 1.2.1. Global Stem Cell Therapy Market, by Region, 2020-2028 (USD Million)
    • 1.2.2. Global Stem Cell Therapy Market, by Cell Source, 2020-2028 (USD Million)
    • 1.2.3. Global Stem Cell Therapy Market, by Type, 2020-2028 (USD Million)
    • 1.2.4. Global Stem Cell Therapy Market, by Therapeutic Application, 2020-2028 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Stem Cell Therapy Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Stem Cell Therapy Market Dynamics

  • 3.1. Stem Cell Therapy Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising number of GMP-certification approvals for cell therapy production facilities
      • 3.1.1.2. Increasing clinical trials for stem cell based-therapies
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost of cell-based research
      • 3.1.2.2. Ethical concerns related to embryonic stem cells
    • 3.1.3. Market Opportunities
      • 3.1.3.1. The emergence of iPSCs as an alternative to ESCs
      • 3.1.3.2. Increasing demand for cell & gene therapies

Chapter 4. Global Stem Cell Therapy Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2019-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Stem Cell Therapy Market, by Cell Source

  • 6.1. Market Snapshot
  • 6.2. Global Stem Cell Therapy Market by Cell Source, Performance - Potential Analysis
  • 6.3. Global Stem Cell Therapy Market Estimates & Forecasts by Cell Source 2019-2028 (USD Million)
  • 6.4. Stem Cell Therapy Market, Sub Segment Analysis
    • 6.4.1. Adipose Tissue-Derived Mscs (Mesenchymal Stem Cells),
    • 6.4.2. Bone Marrow-Derived Mscs,
    • 6.4.3. Placental/Umbilical Cord-Derived Mscs, And
    • 6.4.4. Other Cell Sources

Chapter 7. Global Stem Cell Therapy Market, by Type

  • 7.1. Market Snapshot
  • 7.2. Global Stem Cell Therapy Market by Type, Performance - Potential Analysis
  • 7.3. Global Stem Cell Therapy Market Estimates & Forecasts by Type 2019-2028 (USD Million)
  • 7.4. Stem Cell Therapy Market, Sub Segment Analysis
    • 7.4.1. Allogeneic Stem Cell Therapy
    • 7.4.2. Autologous Stem Cell Therapy

Chapter 8. Global Stem Cell Therapy Market, by Therapeutic Application

  • 8.1. Market Snapshot
  • 8.2. Global Stem Cell Therapy Market by Therapeutic Application, Performance - Potential Analysis
  • 8.3. Global Stem Cell Therapy Market Estimates & Forecasts by Therapeutic Application 2019-2028 (USD Million)
  • 8.4. Stem Cell Therapy Market, Sub Segment Analysis
    • 8.4.1. Musculoskeletal Disorders
    • 8.4.2. Wounds & Injuries,
    • 8.4.3. Cardiovascular Diseases
    • 8.4.4. Surgeries,
    • 8.4.5. Inflammatory & Autoimmune Diseases
    • 8.4.6. Neurological Disorders,
    • 8.4.7. Other

Chapter 9. Global Stem Cell Therapy Market, Regional Analysis

  • 9.1. Stem Cell Therapy Market, Regional Market Snapshot
  • 9.2. North America Stem Cell Therapy Market
    • 9.2.1. U.S. Stem Cell Therapy Market
      • 9.2.1.1. Cell Source estimates & forecasts, 2019-2028
      • 9.2.1.2. Type estimates & forecasts, 2019-2028
      • 9.2.1.3. Therapeutic Application estimates & forecasts, 2019-2028
    • 9.2.2. Canada Stem Cell Therapy Market
  • 9.3. Europe Stem Cell Therapy Market Snapshot
    • 9.3.1. U.K. Stem Cell Therapy Market
    • 9.3.2. Germany Stem Cell Therapy Market
    • 9.3.3. France Stem Cell Therapy Market
    • 9.3.4. Spain Stem Cell Therapy Market
    • 9.3.5. Italy Stem Cell Therapy Market
    • 9.3.6. Rest of Europe Stem Cell Therapy Market
  • 9.4. Asia-Pacific Stem Cell Therapy Market Snapshot
    • 9.4.1. China Stem Cell Therapy Market
    • 9.4.2. India Stem Cell Therapy Market
    • 9.4.3. Japan Stem Cell Therapy Market
    • 9.4.4. Australia Stem Cell Therapy Market
    • 9.4.5. South Korea Stem Cell Therapy Market
    • 9.4.6. Rest of Asia Pacific Stem Cell Therapy Market
  • 9.5. Latin America Stem Cell Therapy Market Snapshot
    • 9.5.1. Brazil Stem Cell Therapy Market
    • 9.5.2. Mexico Stem Cell Therapy Market
  • 9.6. Rest of The World Stem Cell Therapy Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. MEDIPOST
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Anterogen
    • 10.2.3. Regrow Biosciences
    • 10.2.4. Stempeutics Research
    • 10.2.5. CORESTEM
    • 10.2.6. PHARMICELL
    • 10.2.7. NuVasive
    • 10.2.8. RTI Surgical
    • 10.2.9. AlloSource
    • 10.2.10. JCR Pharmaceuticals

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Stem Cell Therapy Market, report scope
  • TABLE 2. Global Stem Cell Therapy Market estimates & forecasts by Region 2019-2028 (USD Million)
  • TABLE 3. Global Stem Cell Therapy Market estimates & forecasts by Cell Source 2019-2028 (USD Million)
  • TABLE 4. Global Stem Cell Therapy Market estimates & forecasts by Type 2019-2028 (USD Million)
  • TABLE 5. Global Stem Cell Therapy Market estimates & forecasts by Therapeutic Application 2019-2028 (USD Million)
  • TABLE 6. Global Stem Cell Therapy Market by segment, estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 7. Global Stem Cell Therapy Market by region, estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 8. Global Stem Cell Therapy Market by segment, estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 9. Global Stem Cell Therapy Market by region, estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 10. Global Stem Cell Therapy Market by segment, estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 11. Global Stem Cell Therapy Market by region, estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 12. Global Stem Cell Therapy Market by segment, estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 13. Global Stem Cell Therapy Market by region, estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 14. Global Stem Cell Therapy Market by segment, estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 15. Global Stem Cell Therapy Market by region, estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 16. U.S. Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 17. U.S. Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 18. U.S. Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 19. Canada Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 20. Canada Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 21. Canada Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 22. UK Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 23. UK Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 24. UK Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 25. Germany Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 26. Germany Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 27. Germany Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 28. RoE Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 29. RoE Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 30. RoE Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 31. China Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 32. China Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 33. China Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 34. India Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 35. India Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 36. India Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 37. Japan Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 38. Japan Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 39. Japan Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 40. RoAPAC Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 41. RoAPAC Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 42. RoAPAC Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 43. Brazil Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 44. Brazil Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 45. Brazil Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 46. Mexico Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 47. Mexico Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 48. Mexico Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 49. RoLA Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 50. RoLA Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 51. RoLA Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 52. Row Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 53. Row Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 54. Row Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 55. List of secondary sources, used in the study of global Stem Cell Therapy Market
  • TABLE 56. List of primary sources, used in the study of global Stem Cell Therapy Market
  • TABLE 57. Years considered for the study
  • TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Stem Cell Therapy Market, research methodology
  • FIG 2. Global Stem Cell Therapy Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Stem Cell Therapy Market, key trends 2021
  • FIG 5. Global Stem Cell Therapy Market, growth prospects 2022-2028
  • FIG 6. Global Stem Cell Therapy Market, porters 5 force model
  • FIG 7. Global Stem Cell Therapy Market, pest analysis
  • FIG 8. Global Stem Cell Therapy Market, value chain analysis
  • FIG 9. Global Stem Cell Therapy Market by segment, 2019 & 2028 (USD Million)
  • FIG 10. Global Stem Cell Therapy Market by segment, 2019 & 2028 (USD Million)
  • FIG 11. Global Stem Cell Therapy Market by segment, 2019 & 2028 (USD Million)
  • FIG 12. Global Stem Cell Therapy Market by segment, 2019 & 2028 (USD Million)
  • FIG 13. Global Stem Cell Therapy Market by segment, 2019 & 2028 (USD Million)
  • FIG 14. Global Stem Cell Therapy Market, regional snapshot 2019 & 2028
  • FIG 15. North America Stem Cell Therapy Market 2019 & 2028 (USD Million)
  • FIG 16. Europe Stem Cell Therapy Market 2019 & 2028 (USD Million)
  • FIG 17. Asia pacific Market 2019 & 2028 (USD Million)
  • FIG 18. Latin America Stem Cell Therapy Market 2019 & 2028 (USD Million)
  • FIG 19. Global Stem Cell Therapy Market, company Market share analysis (2021)